Bavarian Nordic News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.03.24	Bavarian Nordic Publishes Annual Report 2023 (GlobeNewswire)
23.02.24	Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines Agency (GlobeNewswire)
21.02.24	Bavarian Nordic delivered record financial results in 2023 (GlobeNewswire)
13.12.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
13.12.23	New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic (GlobeNewswire)
30.11.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
30.11.23	Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise (GlobeNewswire)
22.11.23	Bavarian Nordic to hold Capital Markets Days in February 2024 (GlobeNewswire)
16.11.23	Bavarian Nordic Announces Interim Results for the First Nine Months of 2023 (GlobeNewswire)
25.10.23	Bavarian Nordic’s Mpox Vaccine Receives Recommendation from U.S. CDC Advisory Committee for Routine Use in Adults at Risk (GlobeNewswire)
13.09.23	Bavarian Nordic Awarded Another Contract to Supply Smallpox Vaccines for EU Strategic Reserve (GlobeNewswire)
04.09.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
01.09.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
31.08.23	Bavarian Nordic Provides Update on COVID-19 Booster Vaccine Program (GlobeNewswire)
23.08.23	Bavarian Nordic Announces First Half 2023 Results (GlobeNewswire)
06.08.23	Bavarian Nordic Reports Positive Phase 3 Topline Results for Chikungunya Virus Vaccine in Adults and Adolescents (GlobeNewswire)
03.08.23	Bavarian Nordic Receives USD 120 Million Contract for the Manufacturing of Smallpox and Mpox Vaccine from the U.S. Government (GlobeNewswire)
22.07.23	Bavarian Nordic Provides Update on RSV Vaccine Program (GlobeNewswire)
27.06.23	Bavarian Nordic Reports Phase 3 Topline Results for its COVID-19 Booster Vaccine Candidate (GlobeNewswire)
23.06.23	Bavarian Nordic to Supply Smallpox Vaccines for EU Strategic Reserve (GlobeNewswire)
20.06.23	Bavarian Nordic Reports Data from a Phase 3 Clinical Trial of its VLP-Based Chikungunya Virus Vaccine in Adults =65 Years of Age (GlobeNewswire)
16.06.23	Bavarian Nordic Reports 12-Month Durability Data from a Phase 2 Clinical Trial of its COVID-19 Vaccine Candidate (GlobeNewswire)
12.06.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
23.05.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
23.05.23	Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise (GlobeNewswire)
17.05.23	Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program (GlobeNewswire)
15.05.23	Bavarian Nordic Completes Acquisition of Travel Vaccine Portfolio from Emergent BioSolutions (GlobeNewswire)
09.05.23	Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations (GlobeNewswire)
09.05.23	Bavarian Nordic Announces Interim Results for the First Three Months of 2023 (GlobeNewswire)
01.05.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
25.04.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
11.04.23	Bavarian Nordic Completes Case Accrual for RSV Phase 3 Clinical Trial (GlobeNewswire)
30.03.23	Resolutions of the Annual General Meeting 2023 of Bavarian Nordic A/S (GlobeNewswire)
17.03.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
16.03.23	Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise (GlobeNewswire)
07.03.23	Bavarian Nordic A/S – Notice Convening Annual General Meeting (GlobeNewswire)
02.03.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
02.03.23	Bavarian Nordic Publishes Annual Report 2022 (GlobeNewswire)
24.02.23	Bavarian Nordic to Host Full Year 2022 Results Conference Call (GlobeNewswire)
23.02.23	Bavarian Nordic A/S - Registration of Share Capital Increase of 7,046,839 New Shares Completed (GlobeNewswire)
20.02.23	Bavarian Nordic A/S Announces Completion of Directed Issue of 7,046,839 New Ordinary Shares (GlobeNewswire)
20.02.23	Bavarian Nordic A/S Launches Offering of up to 7,046,839 New Shares in a Directed Issue (GlobeNewswire)
20.02.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
15.02.23	Bavarian Nordic to Acquire Portfolio of Travel Vaccines from Emergent BioSolutions (GlobeNewswire)
15.02.23	Bavarian Nordic Provides Pipeline Update and Financial Guidance for 2023 (GlobeNewswire)
24.11.22	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
23.11.22	Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise (GlobeNewswire)
17.11.22	Bavarian Nordic Enters Joint Procurement Agreement with the European Health Emergency Preparedness and Response Authority (HERA) for Monkeypox Vaccines (GlobeNewswire)
11.11.22	Bavarian Nordic to Present at Jefferies 2022 London Healthcare Conference (GlobeNewswire)
09.11.22	Bavarian Nordic Announces Interim Results for the First Nine Months of 2022 (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	28.56	2.99 %	K V
Swiss Life Hldg	713.80	2.03 %	K V
Part Grp Hldg	1’243.50	1.10 %	K V
Zurich Insur Gr	544.20	1.00 %	K V
Swiss Re	131.95	0.57 %	K V
Alcon	76.42	-0.62 %	K V
Nestle	74.38	-0.67 %	K V
Geberit	510.40	-0.82 %	K V
Sika	212.20	-1.67 %	K V
CieFinRichemont	134.25	-2.65 %	K V

mehr

22.08.24		Bavarian Nordic-Aktie im Rally-Modus: Bavarian Nordic übertrifft Erwartungen um Längen
22.08.24		Ausblick: Bavarian Nordic legt Quartalsergebnis vor
20.08.24		Bavarian Nordic-Aktie dreht ins Minus: Produktion von Mpox-Impfstoff wird gesteigert - Halbjahreszahlen stehen an
23.08.22		Ausblick: Bavarian Nordic gewährt Anlegern Blick in die Bücher

22.08.24

Bavarian Nordic-Aktie im Rally-Modus: Bavarian Nordic übertrifft Erwartungen um Längen

22.08.24

Ausblick: Bavarian Nordic legt Quartalsergebnis vor

20.08.24

Bavarian Nordic-Aktie dreht ins Minus: Produktion von Mpox-Impfstoff wird gesteigert - Halbjahreszahlen stehen an

23.08.22

Ausblick: Bavarian Nordic gewährt Anlegern Blick in die Bücher

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Bavarian Nordic A/S

Aktien Top/Flop

Bavarian Nordic Peer Group Nachrichten

Meistgelesene Nachrichten